Rakovina Therapeutics Inc.
RKVTF
$0.13
-$0.01-7.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -249.17% | -172.16% | -99.53% | -54.41% | -34.02% |
| Total Depreciation and Amortization | -1.13% | -7.06% | -2.82% | -1.59% | -1.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.88% | 320.85% | 2.00% | -9.20% | 80.08% |
| Change in Net Operating Assets | -257.76% | 75.14% | -450.65% | -852.58% | 151.11% |
| Cash from Operations | -581.05% | -348.44% | -353.66% | -247.32% | 46.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 114.32% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.22% | -- | -- | 69.15% | -- |
| Cash from Financing | 190.01% | -- | -- | -- | 15.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.80% | -348.44% | 372.68% | -181.38% | 97.47% |